Highfield Diagnostics Ltd. of Southampton at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

Highfield Diagnostics Ltd.

University of Southampton, Highfield, SO17 1BJ Southampton
United Kingdom of Great Britain and Northern Ireland

This company is co-exhibitor of
ABHI Association of British HealthTech Industries

Hall map

MEDICA 2018 hall map (Hall 16): stand F18-2

Fairground map

MEDICA 2018 fairground map: Hall 16

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.02  Diagnostic rapid tests

Diagnostic rapid tests

Our products

Product category: Diagnostic rapid tests

diagnostic rapid tests

Highfield Diagnostics enables lateral flow test manufacturers the opportunity to add newer functionalities and improved performance capabilities to their lateral flow tests.

Highfield Diagnostics’ specialist flow technology assists the implementation of multiplexed and/or semi-quantitative detection within lateral flow tests, or alternatively enables performance improvements through enhanced sensitivity and limit-of-detection.

More Less

About us

Company details

Highfield Diagnostics is a recent spinout from the University of Southampton in the United Kingdom. Over the last three years, the Highfield Diagnostics team within the University has developed a laser-based technology that enables the creation of shaped flow paths with advanced flow-control in lateral flow tests. Highfield Diagnostics’ mission is to use this platform technology to provide breakthrough solutions for several issues currently encountered by lateral flow manufacturers. By enabling newer capabilities such as multiplexed and semi-quantitative testing currently unavailable with lateral flow tests, Highfield Diagnostics aim is to bring a change to lateral-flow test enabled rapid point-of-care diagnostics.

Within the domain of rapid testing, Highfield Diagnostics is developing the following lateral flow products:

1.     A multiplexed test that presents a population-screening pathway for Tuberculosis testing.

2.     A multiplexed test for human neglected tropical disease, with a veterinary test to follow soon.

A semi-quantitative test for inflammation markers, CRP and SAA1 for applications in Dementia.

More Less